Chromogranin A and the tumor microenvironment (Q37809767)

23 August 2017

Chromogranin A and the tumor microenvironment (English)

1 reference

23 August 2017

1

0 references

publication date

16 November 2010

1 reference

Cellular and Molecular Neurobiology

23 August 2017

1 reference

23 August 2017

30

1 reference

23 August 2017

8

1 reference

23 August 2017

1163-1170

1 reference

https://scigraph.springernature.com/pub.10.1007/s10571-010-9587-8

23 August 2017

0 references

cites work

Characterisation of circulating chromogranin A in human cancer patients

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10571-010-9587-8

Biochemistry of the chromogranin A protein family

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10571-010-9587-8

Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?

21 January 2018

1 reference

12 December 2020

The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.

1 reference

12 December 2020

Plasmin in pericellular proteolysis and cellular invasion.

1 reference

12 December 2020

Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain

1 reference

12 December 2020

The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration

1 reference

12 December 2020

Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology

1 reference

12 December 2020

Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure.

1 reference

12 December 2020

Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer

1 reference

12 December 2020

Frog chromogranin A messenger ribonucleic acid encodes three highly conserved peptides. Coordinate regulation of proopiomelanocortin and chromogranin A gene expression in the pars intermedia of the pituitary during background color adaptation.

1 reference

12 December 2020

Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

1 reference

12 December 2020

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

1 reference

12 December 2020

Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.

1 reference

12 December 2020

Granins and granin-related peptides in neuroendocrine tumours

1 reference

12 December 2020

ERM proteins and merlin: integrators at the cell cortex

1 reference

12 December 2020

Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods

1 reference

12 December 2020

Drug penetration in solid tumours

1 reference

12 December 2020

Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.

1 reference

12 December 2020

Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides.

1 reference

12 December 2020

Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center

1 reference

12 December 2020

Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2

1 reference

12 December 2020

Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma

1 reference

12 December 2020

Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide

1 reference

12 December 2020

Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer

1 reference

12 December 2020

Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man.

1 reference

12 December 2020

Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.

1 reference

12 December 2020

Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage

1 reference

12 December 2020

Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF- -elicited endothelial activation

1 reference

12 December 2020

Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin

1 reference

12 December 2020

Chromogranin A induces a neurotoxic phenotype in brain microglial cells.

1 reference

12 December 2020

Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells

1 reference

12 December 2020

The chromogranin-secretogranin family

1 reference

12 December 2020

Catestatin: a multifunctional peptide from chromogranin A

1 reference

12 December 2020

Drug resistance and the solid tumor microenvironment

1 reference

12 December 2020

Secretion of chromogranin A by peptide-producing endocrine neoplasms

1 reference

12 December 2020

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

1 reference

12 December 2020

The potential biological and clinical significance of the soluble tumor necrosis factor receptors

1 reference

12 December 2020

Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion

1 reference

12 December 2020

Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.

1 reference

12 December 2020

Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine

1 reference

12 December 2020

The chromogranin A-derived vasostatins: new players in the endocrine heart

1 reference

12 December 2020

Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models

1 reference

12 December 2020

Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure

1 reference

12 December 2020

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor

1 reference

12 December 2020

Endothelial handling of chromogranin A

1 reference

12 December 2020

Role of vasostatin-1 C-terminal region in fibroblast cell adhesion.

1 reference

12 December 2020

Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker

1 reference

12 December 2020

10.1007/S10571-010-9587-8

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21080056